alnylam
An Associate Director MedEd Marketing, KOL Education at Alnylam leads national strategy and execution for HCP education and peer-to-peer engagement across the TTR franchise, developing scalable and innovative initiatives to support brand goals and elevate AMVUTTRA's presence.
Headquarters
Cambridge, Massachusetts, United States
Company Size
1001-5000 employees
Founded
2002
Alnylam is a biopharmaceutical company that has pioneered RNA interference (RNAi) therapeutics, an innovative class of medicines that treats diseases by silencing the genes that cause or contribute to them. The company develops RNAi-based medicines targeting both rare and prevalent diseases across multiple therapeutic areas, with approved products and a robust investigational pipeline. Driven by science and inspired by patients, Alnylam is committed to delivering transformational medicines that address diseases at their genetic source.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for alnylam.
10% above the average for this role
Associate Director Marketing, Professional Education Portfolio
Harrow, Inc.
Sr. Director, HCP TTR Marketing
Alnylam Pharmaceuticals
Associate Director, US HCP Peer-to-Peer (P2P) Marketing, gMG & NMOSD, Rare Neurology
AstraZeneca
Associate Director, US HCP Peer-to-Peer Marketing, GMG & NMOSD, Rare Neurology
AstraZeneca
Marketing Senior Manager, Peer-to-peer (Remote)
lifelancer
Senior Manager, Peer-to-Peer Strategy & Engagement
Brinova Fastigheter AB